Zobrazeno 1 - 6
of 6
pro vyhledávání: '"K C, Raffaele"'
Publikováno v:
Alzheimer disease and associated disorders. 9(4)
Physostigmine, a reversible and nonselective cholinesterase inhibitor, administered by steady-state, continuous intravenous infusion to carefully selected subjects with mild-moderate Alzheimer disease, produced significant but modest improvement in m
Publikováno v:
Psychopharmacology bulletin. 27(3)
Alzheimer's disease (AD) is accompanied by depletion of cholinergic markers in the central nervous system. In an attempt to improve cognitive function in AD, arecoline (a muscarinic cholinergic receptor agonist) was given to patients with probable or
Autor:
K C, Raffaele, C, Rees
Publikováno v:
Neurotoxicology. 11(2)
Dose/response assessment for non-carcinogenic endpoints typically uses the Acceptable Daily Intake (ADI) or Reference Dose (RfD) approach, in which a dose believed to cause no toxic effect is divided by a number of safety or uncertainty factors (e.g.
Autor:
D S, Olton, K C, Raffaele
Publikováno v:
NIDA research monograph. 97
Animal models provide important information about strategies that can be used to assess the effects of chronic exposure to drugs or other compounds. Furthermore, when used in conjunction with analyses designed to utilize the many advantages of animal
Autor:
K C, Raffaele, D S, Olton
Publikováno v:
Behavioral neuroscience. 102(3)
Hippocampal lesions in rats lead to an impairment of performance in spatial delayed conditional discriminations. The effect of such lesions on nonspatial tasks is controversial. In monkeys, both the hippocampus and the amygdala are involved in nonspa
Publikováno v:
Toxicology and applied pharmacology. 83(3)
Blood carboxyhemoglobin (HbCO) was determined 15, 30, 45, 60, 90, and 120 min following ip injection of 2.5, 5, 10, 20, and 40 ml pure carbon monoxide (CO)/kg body wt in rats. These CO doses produced HbCO concentrations of 12, 24, 35, 45, and 60%, re